Medtronic (MDT) 2024 Wells Fargo Healthcare Conference summary

Industry trends and innovation

• Medtech industry is experiencing strong innovation, especially in areas with high patient need such as diabetes, AFib, and hypertension, leading to healthy growth and pricing.

• Digital technologies, including AI, supercomputing, and robotics, are increasingly integrated into medtech, driving excitement and transformation.

• Procedure volumes have normalized post-COVID, with healthy growth rates expected to continue globally.

• GLP-1s have impacted bariatric procedures, but growth is expected to resume in 2025.

• Regulatory environment at the FDA is expected to remain supportive of innovation and patient safety despite leadership changes.

Financial performance and growth drivers

• Consistent mid-single digit revenue growth has been achieved for seven quarters, with high single-digit EPS growth anticipated in the back half of the year.

• Innovation and operational discipline are driving both top and bottom line improvements.

• Pricing has turned slightly positive, supported by a focus on new product launches and a growing Vitality Index, with over 20% of revenue from products launched in the last three years.

• Gross margins are stabilizing, with improvements expected as inflation eases and high-margin products are prioritized.

• The company is managing to a mid-single digit organic sales growth and high single-digit EPS growth algorithm beyond fiscal 2025.

AI, digital, and operational strategy

• AI-based products are being monetized through subscription models and direct charges, with about half of AI-approved products generating specific revenue.

• Centralized AI and digital strategy is led by a chief technology officer, leveraging enterprise platforms for efficiency.

• Digitization and global capability centers, such as R&D in India, are helping control SG&A growth and improve operational leverage.